Patents by Inventor Mark George Sauliner

Mark George Sauliner has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Covalent Binding Compounds for the Treatment of Disease
    Publication number: 20240165239
    Abstract: Compounds and compositions that have a Protein Recognition Moiety bound to an electrophile for the selective covalent modification of targeted proteins to treat disorders mediated by the targeted protein are described.
    Type: Application
    Filed: September 5, 2023
    Publication date: May 23, 2024
    Applicant: Hyku Biosciences Inc.
    Inventors: Guillaume Barbe, Mark George Sauliner, William John Greenlee, Soumya Ray
  • COVALENT KRAS-BINDING COMPOUNDS FOR THERAPEUTIC PURPOSES
    Publication number: 20230406854
    Abstract: Heteroaryl sulfonyl compounds and compositions that have a KRAS Recognition Moiety bound to an electrophile for the selective covalent modification of KRAS, for example a mutant KRAS, to treat KRAS-mediated disorders are described.
    Type: Application
    Filed: September 5, 2023
    Publication date: December 21, 2023
    Applicant: Umbra Therapeutics, Inc.
    Inventors: Guillaume Barbe, Mark George Sauliner, William John Greenlee, Soumya Ray
  • COVALENT CDK2-BINDING COMPOUNDS FOR THERAPEUTIC PURPOSES
    Publication number: 20230406853
    Abstract: Heteroaryl sulfonyl compounds and compositions that have a CDK2 Recognition Moiety bound to an electrophile for the selective covalent modification of CDK2 to treat CDK2-mediated disorders are described.
    Type: Application
    Filed: September 5, 2023
    Publication date: December 21, 2023
    Applicant: Umbra Therapeutics, Inc.
    Inventors: Guillaume Barbe, Mark George Sauliner, William John Greenlee, Soumya Ray